Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-03

Clinical Trial Update: Effect of Docosahexaenoic Acid Supplementation on Microbiome in Obese ChiLdrEn. [Phase 4]

View source ↗

Summary

Phase 4 trial exploring the effect of docosahexaenoic acid supplementation on the microbiome in children with obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Docosahexaenoic acid supplementation (docosahexaenoic acid)

Snippet

Sponsor: University of Milan | Conditions: Childhood Obesity | Phase 4 | Status: UNKNOWN